February 12, 2016
Recommended Topic Related To:

Simbrinza

"Almost all of the 41 million estimated contact lens wearers in the United States may be engaging in at least one behavior known to increase their risk of eye infections, according to a report published today by the Centers for Disease Control and"...

A A A

Simbrinza

Indications
Dosage
How Supplied

INDICATIONS

SIMBRINZA* (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of SIMBRINZA in the affected eye(s) three times daily. Shake well before use. SIMBRINZA ophthalmic suspension may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.

HOW SUPPLIED

Dosage Forms And Strengths

Suspension containing 10 mg/mL brinzolamide and 2 mg/mL brimonidine tartrate.

SIMBRINZA (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is supplied in white low density polyethylene (LDPE) DROP-TAINER* bottles with a natural LDPE dispensing-tip and light green polypropylene cap as follows:

8 mL in a 10 mL bottle NDC 0065-4147-27

Storage And Handling

Store SIMBRINZA at 2 - 25°C (36 - 77°F).

Alcon Laboratories, Inc., Fort Worth, Texas 76134 USA, 1-800-757-9195, alcon.medinfo@alcon.com. Revised: May 2014

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/23/2015

Indications
Dosage
How Supplied

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.